BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36327469)

  • 1. Impact and outcomes of liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension.
    Cortese S; Tellado JM
    Cir Cir; 2022; 90(5):579-587. PubMed ID: 36327469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of laparoscopic hepatectomy in patients with hepatocellular carcinoma and portal hypertension: interim analysis of an open prospective study.
    Lim C; Osseis M; Lahat E; Doussot A; Sotirov D; Hemery F; Lantéri-Minet M; Feray C; Salloum C; Azoulay D
    Surg Endosc; 2019 Mar; 33(3):811-820. PubMed ID: 30003350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laparoscopic Liver Resection for Hepatocellular Carcinoma in Child-Pugh A Patients With and Without Portal Hypertension: A Multicentre Study.
    Casellas-Robert M; Lim C; Lopez-Ben S; Lladó L; Salloum C; Codina-Font J; Comas-Cufí M; Ramos E; Figueras J; Azoulay D
    World J Surg; 2020 Nov; 44(11):3915-3922. PubMed ID: 32661688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of laparoscopic liver resection in patients with hepatocellular carcinoma and portal hypertension: a case-matched study.
    Molina V; Sampson-Dávila J; Ferrer J; Fondevila C; Díaz Del Gobbo R; Calatayud D; Bruix J; García-Valdecasas JC; Fuster J
    Surg Endosc; 2018 May; 32(5):2345-2354. PubMed ID: 29218665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microwave ablation versus laparoscopic resection for hepatocellular carcinoma in patients with clinically significant portal hypertension: a propensity score-matched study of postoperative liver decompensation.
    Yu H; Zhao F; Men X; Zhu H; Yan J; Liu Z; Liu Q; Feng Y; Wang L; Meng M; Zhu Q; Zhao X
    Eur Radiol; 2024 May; 34(5):3226-3235. PubMed ID: 37875593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and feasibility of laparoscopic liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a propensity score-matched study.
    Zheng J; Feng X; Liang Y; Cai J; Shi Z; Kirih MA; Tao L; Liang X
    Surg Endosc; 2021 Jul; 35(7):3267-3278. PubMed ID: 32632488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity of portal hypertension and prediction of postoperative liver failure after liver resection in patients with Child-Pugh grade A cirrhosis.
    Chen X; Zhai J; Cai X; Zhang Y; Wei L; Shi L; Wu D; Shen F; Lau WY; Wu M
    Br J Surg; 2012 Dec; 99(12):1701-10. PubMed ID: 23132418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients.
    Giannini EG; Savarino V; Farinati F; Ciccarese F; Rapaccini G; Marco MD; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
    Liver Int; 2013 Nov; 33(10):1594-600. PubMed ID: 23654354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis and safety of laparoscopic hepatectomy for BCLC stage 0/A hepatocellular carcinoma with clinically significant portal hypertension: a multicenter, propensity score-matched study.
    Xia F; Zhang Q; Ndhlovu E; Zheng J; Yuan M; Gao H; Xia G
    Surg Endosc; 2024 Feb; 38(2):799-812. PubMed ID: 38062182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are inflammation-based markers useful in patients with hepatocellular carcinoma and clinically significant portal hypertension after liver resection?
    Qin L; Li C; Xie F; Wang Z; Wen T
    Biosci Trends; 2020 Sep; 14(4):297-303. PubMed ID: 32641640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors.
    Llop E; Berzigotti A; Reig M; Erice E; Reverter E; Seijo S; Abraldes JG; Bruix J; Bosch J; García-Pagan JC
    J Hepatol; 2012 Jan; 56(1):103-8. PubMed ID: 21827733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis.
    Liu J; Zhang H; Xia Y; Yang T; Gao Y; Li J; Wu Y; Shen F
    HPB (Oxford); 2019 Jan; 21(1):1-13. PubMed ID: 30082213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension.
    Azoulay D; Ramos E; Casellas-Robert M; Salloum C; Lladó L; Nadler R; Busquets J; Caula-Freixa C; Mils K; Lopez-Ben S; Figueras J; Lim C
    JHEP Rep; 2021 Feb; 3(1):100190. PubMed ID: 33294830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of clinically significant portal hypertension on the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation: a propensity score matching analysis.
    Fang KC; Su CW; Chiou YY; Lee PC; Chiu NC; Liu CA; Chen PH; Kao WY; Huang YH; Huo TI; Hou MC; Lin HC; Wu JC
    Eur Radiol; 2017 Jun; 27(6):2600-2609. PubMed ID: 27678133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.
    Berardi G; Morise Z; Sposito C; Igarashi K; Panetta V; Simonelli I; Kim S; Goh BKP; Kubo S; Tanaka S; Takeda Y; Ettorre GM; Wilson GC; Cimino M; Chan CY; Torzilli G; Cheung TT; Kaneko H; Mazzaferro V; Geller DA; Han HS; Kanazawa A; Wakabayashi G; Troisi RI
    J Hepatol; 2020 Jan; 72(1):75-84. PubMed ID: 31499131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of albumin-bilirubin grade and clinically significant portal hypertension predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
    Qin L; Li C; Xie F; Wang Z; Wen T
    Biosci Trends; 2021 Mar; 15(1):41-49. PubMed ID: 33627573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic hepatectomy for hepatocellular carcinoma in patients with clinically significant portal hypertension: a systematic review and meta-analysis.
    Xiang ZQ; Wu YC; Qu XL; Luo DJ; Liang H; Ameer S; Long ZT; Dai XM; Zhu Z
    World J Surg Oncol; 2024 Jan; 22(1):3. PubMed ID: 38166925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis.
    Berzigotti A; Reig M; Abraldes JG; Bosch J; Bruix J
    Hepatology; 2015 Feb; 61(2):526-36. PubMed ID: 25212123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative transarterial chemoembolization for laparoscopic liver resection in Child A cirrhotic patients with hepatocellular carcinoma.
    Lopez-Lopez V; Brusadin R; López-Conesa A; Capel A; Navarro-Barrios Á; Cayuela V; Lopez-Banet E; Garzón-Arana A; Parrilla-Paricio P; Robles-Campos R
    Langenbecks Arch Surg; 2021 May; 406(3):763-771. PubMed ID: 33411038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portal hypertension: contraindication to liver surgery?
    Capussotti L; Ferrero A; Viganò L; Muratore A; Polastri R; Bouzari H
    World J Surg; 2006 Jun; 30(6):992-9. PubMed ID: 16736327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.